Neumora Therapeutics is trading 7.2% up in after-hours trading at $1.34, after closing at $1.25 on September 8, 2026, with no verified company-specific catalyst identified.
- No major company-specific announcement, earnings release, or regulatory update dated September 8 was identified; latest listed releases were August 14 financial results and the July 27 NMRA-215 update.
- The broader market was mixed-to-weaker, making the gain appear isolated; confidence remains low pending possible delayed news or filings.